PhoenixBio , Ltd. (6190.T) has a profit margin of 1.05%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
PhoenixBio , Ltd.'s profit margin stands at 1.05% as of June 2026. That compares with -30.07% in the prior-year period — up 103.5% year over year. That is below the Healthcare sector average of 17.63%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
PhoenixBio , Ltd. reported 1.05% in profit margin versus -30.07% a year earlier — a 103.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
PhoenixBio , Ltd. sits lower the Healthcare benchmark (17.63%) with a profit margin of 1.05%. That is roughly 94.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 1.05% for PhoenixBio , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how PhoenixBio , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6190.T next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.